Cantor Fitzgerald Starts Atrium Therapeutics (RNA) at Neutral
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Atrium Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
